Month: July 2026

Kalmar Corporation will arrange a Capital Markets Day 2026 for investors, analysts and media in Helsinki, Finland on Monday, 2 November 2026.

Kalmar Oyj järjestää sijoittajille, analyytikoille ja medialle pääomamarkkinapäivän 2026 Helsingissä, Suomessa, maanantaina 2. marraskuuta 2026.

U.S. Butane Market to Reach USD 30.04 Billion by 2035, While Europe to Grow to USD 40.82 Billion on Industrial and Clean Energy Demand

U.S. Butane Market to Reach USD 30.04 Billion by 2035, While Europe to Grow to USD 40.82 Billion on Industrial and Clean Energy Demand

TORONTO, Ontario, July 22, 2026 (GLOBE NEWSWIRE) — Avante Corp. (TSX.V: XX) (OTC: ALXXF), a global provider of technology-enabled security solutions and services, (“Avante” or the “Company”) is pleased to announce its financial results for fiscal 2026, representing the three and twelve months ended March 31, 2026 (all amounts in Canadian dollars thousands, unless otherwise indicated).

Toronto, July 22, 2026 (GLOBE NEWSWIRE) — The enhanced HST rebate in Ontario continues to have a positive effect on new home sales in Ontario as low-rise units outperform its 10-year average for a third consecutive month and condominium sales increase over the prior year, the Building Industry and Land Development Association (BILD) said today. As full implementation details of the HST rebate are final and legislation has passed, the market has the certainty it needs to take full advantage of the rebate and can continue this positive momentum.

New York, NY, July 22, 2026 (GLOBE NEWSWIRE) — Members of Together for Supportive Cancer Care, a national coalition of over 40 organizations from across sectors working to expand access to Supportive Cancer Care in the United States, stood on stage at the Nasdaq MarketSite in Times Square on Thursday, July 16, to ring the closing bell. You can view the full Closing Bell Ceremony here: https://www.nasdaq.com/videos/together-supportive-cancer-care-rings-nasdaq-stock-market-closing-bell.

STAFFORD, Texas, July 22, 2026 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the regulatory approval to expand FLAMINGO-01 into the United Kingdom.

                  Fast-tracks Repligen’s leadership and customer solution offering in high-growth cell therapy market by adding BioLife’s differentiated, high-margin recurring revenue business

U.S. Masterbatch Market to Reach USD 3.89 Billion and Europe USD 6.30 Billion by 2035, Supported by Sustainable Polymer Innovation

U.S. Masterbatch Market to Reach USD 3.89 Billion and Europe USD 6.30 Billion by 2035, Supported by Sustainable Polymer Innovation

The U.S. AI in Revenue Cycle Management Market is Expected to Reach $90.71 Billion by 2035, While Europe is Projected to Attain $59.82 Billion, Driven by Rising Claim Denials, Healthcare Digitalization, Predictive Analytics, and AI-Powered Revenue Cycle Automation

The U.S. AI in Revenue Cycle Management Market is Expected to Reach $90.71 Billion by 2035, While Europe is Projected to Attain $59.82 Billion, Driven by Rising Claim Denials, Healthcare Digitalization, Predictive Analytics, and AI-Powered Revenue Cycle Automation

FORM 8.3

New York, NY, July 22, 2026 (GLOBE NEWSWIRE) — Cardinal Point Wealth Management is helping cross-border families navigate the complexities of newly proposed U.S. savings vehicles, commonly referred to as “Trump Accounts,” and highlighting the potential tax and planning pitfalls for those with financial ties to both Canada and the United States.

Toronto, ON, July 22, 2026 (GLOBE NEWSWIRE) — Cardinal Point Wealth Management has published a new article examining the significant tax changes affecting Washington residents and the planning considerations for individuals and families evaluating a move to a lower-tax state.

Cambridge, UK – 22 July, 2026 – Healx, an AI-powered, clinical-stage biotech company dedicated to rare diseases, today announced that the first patient has been dosed in its Phase 1/2 dose-escalation and dose-confirmation clinical trial to evaluate the safety and efficacy of HLX-4310, an investigational oral combination of a class I selective HDAC inhibitor and an mTOR inhibitor, in adolescents and adults with relapsed, refractory sarcoma, with a focus on osteosarcoma.

Vancouver, BC & Washington, D.C., July 22, 2026 (GLOBE NEWSWIRE) — Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering companies in the humanoid robotics and embodied AI sector, is pleased to highlight recent developments related to Robots for America (“Robots for America” or the “Coalition”), an industry initiative that was catalyzed by its portfolio company Formic Technologies, Inc. (“Formic”), in which Humanoid Global holds a minority equity interest.